Evidence map›Paper›PMID 33380238›Full record

ArticleBioengineered2021

Long intergenic non-protein coding RNA 960 regulates cancer cell viability, migration and invasion through modulating miR-146a-5p/interleukin 1 receptor associated kinase 1 axis in pancreatic ductal adenocarcinoma.

Yaoxing Huang, Qingqing Yan, Danchun Yu, Xiaojuan Sun, Shuman Jiang, Weidong Li, Lin Jia

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yaoxing HuangDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.
Qingqing YanDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.
Danchun YuDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.
Xiaojuan SunDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.
Shuman JiangDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.
Weidong LiDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.
Lin JiaDepartment of Gastroenterology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , Guangzhou, China.ORCID 0000-0002-5560-267X
Guangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) are considered as crucial regulatory factors in cancer biology. However, the biological function of long intergenic non-protein coding RNA 960 (LINC00960) in the tumorigenesis of pancreatic ductal adenocarcinoma (PDAC) is still unknown. The goal of this study is to investigate the role of LINC00960 in PDAC. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to examine the expression levels of LINC00960 in PDAC tissues and cell lines. After transfection, the loss-of-function models of LINC00960 or interleukin 1 receptor-associated kinase 1 (IRAK1) were established with BxPC-3 cells and Colo357 cells, and the malignant phenotypes of BxPC-3 cells and Colo357 cells were detected by CCK-8 assay, BrdU assay and Transwell assay, respectively. The interactions among LINC00960, miR-146a-5p and IRAK1 were predicted by bioinformatics analysis, and verified by luciferase reporter assay, RNA immunoprecipitation assay and RNA pull-down assay. The regulatory functions of LINC00960 and miR-146a-5p on IRAK1 were detected by Western blot. We demonstrated that the LINC00960 expression was increased in PDAC tissues and cell lines. Knocking down LINC00960 or IRAK1 could repress the viability, migration, and invasion of BxPC-3 and Colo357 cells. LINC00960 functioned as a molecular sponge for miR-146a-5p, and IRAK1 was verified as a target gene of miR-146a-5p. Additionally, LINC00960 could up-regulate IRAK1 expression via repressing miR-146a-5p, and the oncogenic properties of LINC00960 were partly reversed by miR-146a-5p. Our findings reveal that LINC00960 is a promoter of PDAC progression through regulating miR-146a-5p/IRAK1axis.

Indexed as

AdenocarcinomaCell Line, TumorCell MovementCell SurvivalHumansInterleukin-1 Receptor-Associated KinasesMicroRNAsNeoplasm InvasivenessPancreasPancreatic NeoplasmsRNA, Long NoncodingInterleukin-1 Receptor-Associated KinasesMicroRNAsMIRN146 microRNA, humanRNA, Long NoncodingIRAK1LINC00960miR-146a-5ppancreatic ductal adenocarcinoma

Identifiers

PMID33380238
PMCPMC8806237
OpenAlexW3113514998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.